NCT05954832 A Study of Changes in Heart Function and Blood Flow in People Receiving Anesthesia
| NCT ID | NCT05954832 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Condition | Anesthesia |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2023-07-13 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2023-07-13 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to understand changes in heart function (how the heart pumps blood) and blood flow in people who receive general anesthesia during surgery. The researchers are particularly interested in the heart function and blood flow changes in people who experience low blood pressure (hypotension) after receiving anesthesia.
Eligibility Criteria
Inclusion Criteria: * Adult patients ≥ 18 years of age requiring general anesthesia for surgery * Intubation required for anesthetic management / surgery * Anticipated prep time before incision of 20 minutes * Baseline MAP \>70mmHg Exclusion Criteria: * History of coronary artery disease * History of cardiac disease (e.g., HTN, arrythmias, valvular and structural abnormalities) * History of peripheral artery occlusive disease * Beta-blocker use * Anti-hypertensive medication use * Patients with epidural, spinal, paravertebral, serratus blocks preoperatively * Patients requiring rapid sequence induction (where intubation occurs concurrently with induction) * Emergency surgery
Contact & Investigator
Anahita Dabo-Trubelja, MD
PRINCIPAL INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Frequently Asked Questions
Who can join the NCT05954832 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05954832 currently recruiting?
Yes, NCT05954832 is actively recruiting participants. Contact the research team at daboa@mskcc.org for enrollment information.
Where is the NCT05954832 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT05954832 clinical trial?
NCT05954832 is sponsored by Memorial Sloan Kettering Cancer Center. The principal investigator is Anahita Dabo-Trubelja, MD at Memorial Sloan Kettering Cancer Center. The trial plans to enroll 250 participants.